NCT06593444View on ClinicalTrials.gov

Thalamic Ventral Intermediate Electrical Stimulation for Refractory Familial Cortical Myoclonus with Epilepsy

NANot yet recruitingINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

September 20, 2024

Primary Completion Date

March 20, 2025

Study Completion Date

September 20, 2025

Conditions
Epilepsy (treatment Refractory)
Interventions
PROCEDURE

Thalamic Ventral Intermediate-DBS

Participants will undergo Thalamic Ventral Intermediate-DBS ON with the individual stimulation parameters determined in the parameter determination period, then continue to receive stimulation for the remainder of the study.

All Listed Sponsors
lead

Xuanwu Hospital, Beijing

OTHER

NCT06593444 - Thalamic Ventral Intermediate Electrical Stimulation for Refractory Familial Cortical Myoclonus with Epilepsy | Biotech Hunter | Biotech Hunter